Atlas Trials

A Single Oral Dose, Crossover Comparative PK Study of WD-1603 in Healthy Subjects Under Fasting Conditions

Clinical trial NCT04553978 · UNKNOWN

Trial details

NCT number
NCT04553978
Sponsor
Hong Kong WD Pharmaceutical Co., Limited
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson Disease
Start date
2020-09-18
Primary completion
2021-03-18
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.